Paper · 28536403
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes.
Sala V and 5 others. Biomedicines, 2015. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes. Papers, record 28536403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28536403
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8,698,236 | Differential splicing-in of a proline-rich exon converts alphaNAC into a muscle-specific transcription factor. | Genes Dev | 1996 | https://conductscience.org/library/papers/8698236 | PubMed |
| 2 | 9,473,336 | HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. | Dev Biol | 1998 | https://conductscience.org/library/papers/9473336 | PubMed |
| 3 | 1,319,065 | Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1319065 | PubMed |
| 4 | 8,288,123 | bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. | Genes Dev | 1994 | https://conductscience.org/library/papers/8288123 | PubMed |
| 5 | 9,097,022 | Chemotaxis of skeletal muscle satellite cells. | Dev Dyn | 1997 | https://conductscience.org/library/papers/9097022 | PubMed |
| 6 | 9,551,084 | Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. | Biochim Biophys Acta | 1998 | https://conductscience.org/library/papers/9551084 | PubMed |
| 7 | 24,870,234 | mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). | Nature | 2014 | https://conductscience.org/library/papers/24870234 | PubMed |
| 8 | 9,398,440 | Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. | Dev Biol | 1997 | https://conductscience.org/library/papers/9398440 | PubMed |
| 9 | 17,194,700 | Conditional activation of MET in differentiated skeletal muscle induces atrophy. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17194700 | PubMed |
| 10 | 10,825,239 | Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27. | J Cell Physiol | 2000 | https://conductscience.org/library/papers/10825239 | PubMed |
1 to 10 of 28
See all 28 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 37,985,931 | Age-related nitration/dysfunction of myogenic stem cell activator HGF. | Aging Cell | 2024 | https://conductscience.org/library/papers/37985931 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLTM | 79,811 | PubTator's text mining | https://conductscience.org/library/genes/79811 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28536403
GET https://conductscience.org/api/papers/v1/28536403/references?page=2